Astrazeneca Stock News

Related Stocks: MRK , AZN , IDXX , GILD , CRL , PHG , MRNA , GH , QGEN , ALKS , BHVN , STVN , MTD , VRTX , QURE , ALXN , A , STE ,

Related Stocks: AMGN , NVAX , ITCI , SRPT , BGNE , GH , ALKS , AZN , CRBU , CRL , RLYB , BHVN , ALLK , BPMC , BBIO , IOVA , DCPH , REPL ,

Related Stocks: AMGN , GH , IDXX , ALNY , NVAX , SRPT , ICLR , BHVN , CTLT , CRBU , AZN , RLYB , ABT , ASND , NBIX , DXCM , ARNA , ARGX , DCPH , BBIO , RMD , BPMC , ALLK , IOVA ,

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca''s EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected to become available very soon. The Food and Drug Administration (FDA) granted the EUA for EVUSHELD for pre-exposure prophylaxis of COVID-19 in adults and adolescents (aged 12 and older who weigh 40kg or more) with

The number of active cases of covid19 continues to climb, now standing at 13,321. The recorded figure of 881 new cases on Wednesday is the second highest thus far in the pandemic period. The new cases were from samples taken between Sunday to Tuesday. The death toll is now 2,320 with 17 deaths recorded between Tuesday and Wednesday. The highest recorded number of daily covid19 cases was 984 on Saturday. The Health Ministrys covid19 update on Wednesday said the people who died were eight elderly men, seven elderly women, one middle-aged man, and one middle-aged woman. It said 12 of these people had multiple comorbidities, including a mix of diabetes, hypertension, heart disease, cancer, lung disease, and a history of strokes. Three people had one of the aforementioned medical conditions, while two people had no known medical conditions. There are 516 patients in hospital. Of these, there are 91 people at the Couva Hospital and Multi-Training Facility, with 24 in the intensive care unit and 22 in the high dependency unit.

The drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.

U.S.-listed shares of AstraZeneca were up 0.3% in after-hours trading on Wednesday after the Food and Drug Administration authorized the company''s COVID-19 monoclonal antibodies for pre-exposure prophylaxis in individuals who are immunocompromised or have a history of severe adverse reactions to a COVID-19 vaccine. In both instances, the individuals, who must be at least 12 years old, may not be able to gain protective antibodies through COVID-19 vaccination. This is the first authorization for a pre-exposure prophylaxis therapy in the U.S., though the FDA has already authorized some monoclonal antibodies for post-exposure prophylaxis. AstraZeneca''s therapy, Evusheld, pairs two monoclonal antibodies, to be given in separate injections. It may be effective for six months, the FDA said. AstraZeneca''s stock is up 10.3% so far this year, while the broader S&P 500 has gained 24.8%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Adam Bounds, 41, passed away at Derriford Hospital in Plymouth on May 31 this year after his Covid-19 vaccine caused a ''very rare'' fatal side effect.

SPAIN has exceeded its initial vaccination target. Some 79.4% of the adult population has been vaccinated with two doses, meaning more than 37.6 million people. Also, 38.4 million people have had at least one dose accounting for 81% of the population. More than 77 million doses from Pfizer, Moderna, AstraZeneca and Janssen have been []

Results of a new study indicate patients with lymphoma are more likely to develop post-vaccination Covid-19 infection compared to patients with other blood cancers, highlighting the need for additional precautions People with haematological malignancies (HM) are at a higher risk than healthy individuals for severe and life-threatening Covid-19 illness; furthermore, research suggests that they do not always achieve optimal protection from vaccination. A new study, the first to report on post-vaccination Covid-19 cases in patients with HM, offers preliminary findings about the incidence of breakthrough infection in this vulnerable population. The study, published in Blood, drew data from an open online registry, EPICovidEHA, which was set up in April 2020 by the European Haematology Association Infectious Diseases Working Party (EHA-IDWP) to describe the epidemiology, risk factors, and mortality rates of HM patients. Overall, 3801 valid cases were collected with an overall mortality rate of 31 per cent.

U.S.-listed shares of AstraZeneca AZN, +0.68% were up 0.3% in after-hours trading on Wednesday after the Food and Drug Administration authorized the company's COVID-19 monoclonal antibodies for pre-ex

The world’s largest vaccine manufacturer, India-based Serum Institute, plans to reduce production of the AstraZeneca jab against COVID-19 by at least half, its chief executive said in a television interview. Serum Institute head, Adar Poonawalla said the failure of the Indian government to place any new orders was the reason for plans to slash production. […] The post World’s biggest vaccine maker to slash AstraZeneca production by half appeared first on Daily Nigerian .

Jefferies Financial Group set a GBX 9,100 ($120.67) price objective on AstraZeneca (LON:AZN) in a research note published on Tuesday morning, Borsen Zeitung reports. A number of other research analysts have also recently weighed in on the stock. Barclays reissued an overweight rating and set a £110 ($145.87) price objective on shares of AstraZeneca in [] The post AstraZeneca (LON:AZN) PT Set at GBX 9,100 by Jefferies Financial Group appeared first on ETF Daily News .

Up to one million COVID-19 vaccines are estimated to have expired in Nigeria last month without being used, Reuters reported. According to two sources who spoke to Reuters, it was one of the biggest single losses of doses that shows the difficulty of African nations in getting shots. Governments on the continent of over one [] The post One Million Doses Of AstraZeneca Vaccine Expired In Nigeria Last Month Report appeared first on InsideBusiness - Business News in Nigeria .